Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/15/24
End: 06/15/25
Due: 06/15/26
Phase: N/A
Priority: Normal
Start: 02/14/25
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 09/03/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 10/28/24
End: 01/31/26
Due: 01/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje. | NCT06150209 | BioStem Technologies | user2@example.com | None | 2024-01-15 | 2025-06-15 | 2026-06-15 | - | - | 2025-07-14 |
| Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC | NCT06811909 | BioStem Technologies | user2@example.com | None | 2025-02-14 | 2026-10-31 | 2027-10-31 | - | - | 2025-07-14 |
| A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC | NCT06511596 | BioStem Technologies | user2@example.com | None | 2024-09-03 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM | NCT06565156 | BioStem Technologies | user2@example.com | None | 2024-10-28 | 2026-01-31 | 2027-01-31 | - | - | 2025-07-14 |